These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20428950)

  • 1. Comparison of surrogate serum markers and transient elastography (Fibroscan) for assessing cirrhosis in patients with chronic viral hepatitis.
    Lee MH; Cheong JY; Um SH; Seo YS; Kim DJ; Hwang SG; Yang JM; Han KH; Cho SW
    Dig Dis Sci; 2010 Dec; 55(12):3552-60. PubMed ID: 20428950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis.
    Cheong JY; Um SH; Seo YS; Shin SS; Park RW; Kim DJ; Hwang SG; Lee YJ; Cho M; Yang JM; Kim YB; Park YN; Cho SW
    Hepatogastroenterology; 2012; 59(120):2592-7. PubMed ID: 23178625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of 5 serum markers compared to FibroScan to predict significant liver fibrosis in patients with chronic hepatitis B virus.
    Dong H; Xu C; Zhou W; Liao Y; Cao J; Li Z; Hu B
    Clin Chim Acta; 2018 Aug; 483():145-150. PubMed ID: 29709450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients.
    Fernandes FF; Ferraz ML; Andrade LE; Dellavance A; Terra C; Pereira G; Pereira JL; Campos F; Figueiredo F; Perez RM
    J Clin Gastroenterol; 2015 Mar; 49(3):235-41. PubMed ID: 24714186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients.
    Omran D; Zayed RA; Nabeel MM; Mobarak L; Zakaria Z; Farid A; Hassany M; Saif S; Mostafa M; Saad OK; Yosry A
    Viral Immunol; 2018 May; 31(4):315-320. PubMed ID: 29630460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced liver fibrosis test using ELISA assay accurately discriminates advanced stage of liver fibrosis as determined by transient elastography fibroscan in treatment naïve chronic HCV patients.
    Omran D; Yosry A; Darweesh SK; Nabeel MM; El-Beshlawey M; Saif S; Fared A; Hassany M; Zayed RA
    Clin Exp Med; 2018 Feb; 18(1):45-50. PubMed ID: 28567544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography.
    Tatsumi C; Kudo M; Ueshima K; Kitai S; Takahashi S; Inoue T; Minami Y; Chung H; Maekawa K; Fujimoto K; Akiko T; Takeshi M
    Intervirology; 2008; 51 Suppl 1():27-33. PubMed ID: 18544945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
    Castera L; Winnock M; Pambrun E; Paradis V; Perez P; Loko MA; Asselineau J; Dabis F; Degos F; Salmon D
    HIV Med; 2014 Jan; 15(1):30-9. PubMed ID: 24007567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acoustic radiation force impulse elastography and serum fibrosis markers in chronic hepatitis C.
    Silva Junior RG; Schmillevitch J; Nascimento Mde F; Miranda ML; Brant PE; Schulz PO; Vieira A; Szutan LA
    Scand J Gastroenterol; 2014 Aug; 49(8):986-92. PubMed ID: 24742130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B.
    Jia J; Hou J; Ding H; Chen G; Xie Q; Wang Y; Zeng M; Zhao J; Wang T; Hu X; Schuppan D
    J Gastroenterol Hepatol; 2015 Apr; 30(4):756-62. PubMed ID: 25353058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of liver fibrosis by noncommercial serum markers in comparison with transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral treatment.
    Knop V; Hofmann WP; Buggisch P; Klinker H; Mauss S; Günther R; Hinrichsen H; Hüppe D; Pfeiffer-Vornkahl H; Simon KG; Berg T; Manns MP; Friedrich-Rust M;
    J Viral Hepat; 2019 Feb; 26(2):224-230. PubMed ID: 30315694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).
    Degos F; Perez P; Roche B; Mahmoudi A; Asselineau J; Voitot H; Bedossa P;
    J Hepatol; 2010 Dec; 53(6):1013-21. PubMed ID: 20850886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective comparison of transient elastography, point shear wave elastography, APRI and FIB-4 for staging liver fibrosis in chronic viral hepatitis.
    Udompap P; Sukonrut K; Suvannarerg V; Pongpaibul A; Charatcharoenwitthaya P
    J Viral Hepat; 2020 Apr; 27(4):437-448. PubMed ID: 31799740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.
    Thiele M; Madsen BS; Hansen JF; Detlefsen S; Antonsen S; Krag A
    Gastroenterology; 2018 Apr; 154(5):1369-1379. PubMed ID: 29317276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
    Fontana RJ; Goodman ZD; Dienstag JL; Bonkovsky HL; Naishadham D; Sterling RK; Su GL; Ghosh M; Wright EC;
    Hepatology; 2008 Mar; 47(3):789-98. PubMed ID: 18175357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Fibroscan in predicting the presence of varices in patients with cirrhosis.
    Al-Hamoudi WK; Abdelrahman AA; Helmy A; Anil S; Khamis N; Arafah M; Alswat KA; Suwefy YM; Sanai FM; Al Faleh F; Abdo AA
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1307-12. PubMed ID: 26193054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a model based on biochemical, real‑time tissue elastography and ultrasound data for the staging of liver fibrosis and cirrhosis in patients with chronic hepatitis B.
    Xu SH; Li Q; Hu YP; Ying L
    Mol Med Rep; 2016 Oct; 14(4):3609-19. PubMed ID: 27573619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B.
    Wong GL; Wong VW; Choi PC; Chan AW; Chan HL
    Aliment Pharmacol Ther; 2010 May; 31(10):1095-103. PubMed ID: 20180785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis.
    Floreani A; Cazzagon N; Martines D; Cavalletto L; Baldo V; Chemello L
    Dig Liver Dis; 2011 Nov; 43(11):887-92. PubMed ID: 21783442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study.
    Seo YS; Kim MY; Kim SU; Hyun BS; Jang JY; Lee JW; Lee JI; Suh SJ; Park SY; Park H; Jung EU; Kim BS; Kim IH; Lee TH; Um SH; Han KH; Kim SG; Paik SK; Choi JY; Jeong SW; Jin YJ; Lee KS; Yim HJ; Tak WY; Hwang SG; Lee YJ; Lee CH; Kim DG; Kang YW; Kim YS;
    Liver Int; 2015 Oct; 35(10):2246-55. PubMed ID: 25682719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.